93 related articles for article (PubMed ID: 7668938)
1. Infectious disease marker testing of the autologous blood donor. A case study in clinical ethics.
Domen RE
Arch Pathol Lab Med; 1995 Sep; 119(9):807-10. PubMed ID: 7668938
[TBL] [Abstract][Full Text] [Related]
2. Infectious disease markers in autologous blood donors and first-time volunteer blood donors: 14 years' experience in a blood center.
Hernández JM; Cid J; Claparols M; Mallafré E; Pla R
Haematologica; 2004 Jul; 89(7):889-91. PubMed ID: 15257955
[TBL] [Abstract][Full Text] [Related]
3. [The need for thorough infection screening in donors of autologous blood].
Heim MU; Mempel W
Beitr Infusionsther; 1991; 28():313-6. PubMed ID: 1725645
[TBL] [Abstract][Full Text] [Related]
4. Autologous versus allogeneic transfusion: patients' perceptions and experiences.
Graham ID; Fergusson D; Dokainish H; Biggs J; McAuley L; Laupacis A
CMAJ; 1999 Apr; 160(7):989-95. PubMed ID: 10207337
[TBL] [Abstract][Full Text] [Related]
5. [Expanded serologic infection testing of autologous blood donors: a report of experiences].
Zimmermann R; Weisbach V; Wittmann G; Zingsem J; Neidhardt B; Eckstein R
Beitr Infusionsther Transfusionsmed; 1996; 33():196-200. PubMed ID: 8974693
[TBL] [Abstract][Full Text] [Related]
6. Deferred donor care in a regional hospital blood center in Ghana.
Allain JP; Opare-Sem O; Sarkodie F; Rahman R; Owusu-Ofori S
Transfusion; 2009 Apr; 49(4):669-75. PubMed ID: 19170991
[TBL] [Abstract][Full Text] [Related]
7. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
8. Preparing for inspection: managing regulations and practices surrounding donors with positive infectious disease testing.
Ferschke J
J Clin Apher; 2008; 23(6):191-5. PubMed ID: 18973114
[TBL] [Abstract][Full Text] [Related]
9. Preoperative autologous blood donation in total-hip arthroplasty. A cost-effectiveness analysis.
Healy JC; Frankforter SA; Graves BK; Reddy RL; Beck JR
Arch Pathol Lab Med; 1994 Apr; 118(4):465-70. PubMed ID: 8166599
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of selected viral infections among temporarily deferred donors who returned to donate blood: American Red Cross blood donor study.
Zou S; Musavi F; Notari EP; Fujii KE; Dodd RY;
Transfusion; 2005 Oct; 45(10):1593-600. PubMed ID: 16181210
[TBL] [Abstract][Full Text] [Related]
11. How safe are our safe donors?
Srikrishna A; Sitalakshmi S; Damodar P
Indian J Pathol Microbiol; 1999 Oct; 42(4):411-6. PubMed ID: 11127370
[TBL] [Abstract][Full Text] [Related]
12. [Screening for markers of transfusion-associated infections in autologous blood donation].
Zimmermann R; Schwella N; Weissbach V; Heuft HG; Eckstein R
Beitr Infusionsther Transfusionsmed; 1994; 32():488-91. PubMed ID: 9480148
[TBL] [Abstract][Full Text] [Related]
13. The clinical problem of hepatitis transmission;
Barker LF; Gerety RJ
Prog Clin Biol Res; 1976; 11():163-82. PubMed ID: 799307
[TBL] [Abstract][Full Text] [Related]
14. Autologous blood transfusion: standard of care for the 1990s.
Zond JR
J Am Osteopath Assoc; 1992 May; 92(5):638-40, 643-5. PubMed ID: 1601699
[TBL] [Abstract][Full Text] [Related]
15. Viral markers in a blood donor population.
Mwangi JW
East Afr Med J; 1999 Jan; 76(1):35-7. PubMed ID: 10442146
[TBL] [Abstract][Full Text] [Related]
16. A simple strategy to look back on posttransfusion hepatitis B in a multitransfused patient.
Jongerius JM; van der Poel CL; van Leeuwen EF
Vox Sang; 1998; 75(1):66-9. PubMed ID: 9745157
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serologic markers for transfusion transmitted infectious diseases for allogeneic blood donors in Puerto Rico.
Martínez-Díaz H; Frye-Maldonado AC; Climent-Perís C; Vélez-Rosario R
P R Health Sci J; 1997 Sep; 16(3):255-8. PubMed ID: 9431563
[TBL] [Abstract][Full Text] [Related]
19. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of transfusion-associated viral infections and syphilis among blood donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania.
Matee MI; Lyamuya EF; Mbena EC; Magessa PM; Sufi J; Marwa GJ; Mwasulama OJ; Mbwana J
East Afr Med J; 1999 Mar; 76(3):167-71. PubMed ID: 10442119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
